JPMorgan Hikes IREN Target to $46, Stays Underweight
JPMorgan raises its IREN price target to $46 but preserves an underweight stance, citing structural risk in NVIDIA’s ...
Which Is Safer Index Funds Or Individual Stocks
Safety is a key concern for investors. Learn which option, index funds or individual stocks, offers better security for your investments.
24,450 articles
Milestone Pharmaceuticals Stock Wilted: Midweek Decline
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
Nebius Stock All-Time High: Is Now the Time to Buy?
Nebius stock all-time high sparked a flurry of questions. This guide breaks down the drivers, the risks, and a practi...
Billion Twilio Wakes at 4:30: CEO's Morning Mindset
A billionaire Twilio wakes 4:30 a.m. and blends work with intense personal-finance discipline, illustrating how routi...
Nvidia After Blowout Earnings: Is It a Buy Now Today?
When Nvidia posts a blowout quarter, investors often wonder if the stock remains a smart buy. This article weighs his...
Google Gemini Looks Like a Major Flex, Yet Alphabet Slips
Alphabet's Gemini 3.5 showcases bold AI ambitions, but the stock is sliding as investors reassess ROI and token-based...
Prediction: Here's Much Micron Stock Worth in Two Years
Investing in Micron today means evaluating AI-driven memory demand, pricing power, and the memory market cycle. This ...
Canadian Solar (CSIQ) 2025 Earnings Deep Dive & Outlook
Canadian Solar's Q4 2025 results set the stage for 2025. This deep dive explains what to watch, the margin trajectory...
Tell You're Still Track: Are You on Track to Retire in 2028?
With 2028 in sight, you need a clear read on whether your retirement plan still fits. This guide breaks down how to t...
South Korea Fines Coupang Record $409 Million Data Breach
A regulatory ruling in Seoul levies a record penalty on Coupang for a data breach affecting tens of millions of accou...
Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Prediction: SpaceX Will Cut by Half in Six Months, Again
A leading market analyst argues SpaceX could see a 50% decline in its stock within six months if it goes public, citi...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status